Decibel Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Decibel Therapeutics

11/08/2023 13:30

* Decibel Therapeutics Inc  DBTX.OQ  reported a quarterly
adjusted
loss of 73 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 55 cents per share.
    * Reported revenue was zero​; analysts expected $3.47
million. 
    * Decibel Therapeutics Inc's reported EPS for the quarter
was a
loss of 73 cents​.
    * The mean earnings estimate of analysts had risen by
about 12.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Decibel Therapeutics Inc shares had risen by 34.0% this
quarter and gained 151.7% so far this year.
    * The company reported a quarterly loss of $18.15 million.
    * Wall Street's median 12-month price target for Decibel
Therapeutics Inc is $7.63 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 11 at 12:30 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.55          -0.73          Missed
 Mar. 31 2023      -0.60          -0.53          Beat
 Dec. 31 2022      -0.40          -0.63          Missed
 Sep. 30 2022      -0.69          -0.64          Beat